Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Jones

Showing results (601-610 of 3,665) with videos related to

Pageof 367
Sort By:
Journal of Clinical Microbiology|January 1, 1995
Suggested modifications for disk diffusion susceptibility testing criteria for levofloxacin and sparfloxacin following tests with a predictor panel of ciprofloxacin-resistant clinical isolatesL D Sutton, R N Jones
Biochimica Et Biophysica Acta|November 7, 1993
The targeting of immunoliposomes to tumour cells (A431) and the effects of encapsulated methotrexateM N Jones, M J Hudson
Journal of Drugs in Dermatology : JDD|November 23, 2005
Importance of understanding pharmacokinetic/pharmacodynamic principles in the emergence of resistances, including community-associated Staphylococcus aureusThomas R Fritsche, Ronald N Jones
Antimicrobial Agents and Chemotherapy|February 1, 1993
In vitro antimicrobial activity of CP-99,219, a novel azabicyclo-naphthyridoneB B Gooding, R N Jones
Antimicrobial Agents and Chemotherapy|December 1, 1993
In vitro activity of DU-6859a, a new fluorocyclopropyl quinoloneS A Marshall, R N Jones
Diagnostic Microbiology and Infectious Disease|November 1, 1993
Prediction of bacterial susceptibility to cefpodoxime by using the ceftriaxone minimum inhibitory concentration resultR N Jones, G E Zurenko
Psychological Medicine|July 7, 2000
Dimensions of the Mini-Mental State Examination among community dwelling older adultsR N Jones, J J Gallo
Drugs|March 16, 2000
Oxazolidinones: a reviewD I Diekema, R N Jones
Experimental Dermatology|August 10, 1999
The hydrophobic surface barrier of mammalian hairL N Jones, D E Rivett
Hospital Pharmacy|April 9, 1989
Concurrent review of the duration of antimicrobial prophylaxis in surgeryP D O'Melia, W N Jones
Pageof 367

Showing results (601-610 of 3,665) with videos related to

Sort By:
Pageof 367
Journal of Clinical Microbiology|January 1, 1995
Suggested modifications for disk diffusion susceptibility testing criteria for levofloxacin and sparfloxacin following tests with a predictor panel of ciprofloxacin-resistant clinical isolatesL D Sutton, R N Jones
Biochimica Et Biophysica Acta|November 7, 1993
The targeting of immunoliposomes to tumour cells (A431) and the effects of encapsulated methotrexateM N Jones, M J Hudson
Journal of Drugs in Dermatology : JDD|November 23, 2005
Importance of understanding pharmacokinetic/pharmacodynamic principles in the emergence of resistances, including community-associated Staphylococcus aureusThomas R Fritsche, Ronald N Jones
Antimicrobial Agents and Chemotherapy|February 1, 1993
In vitro antimicrobial activity of CP-99,219, a novel azabicyclo-naphthyridoneB B Gooding, R N Jones
Antimicrobial Agents and Chemotherapy|December 1, 1993
In vitro activity of DU-6859a, a new fluorocyclopropyl quinoloneS A Marshall, R N Jones
Diagnostic Microbiology and Infectious Disease|November 1, 1993
Prediction of bacterial susceptibility to cefpodoxime by using the ceftriaxone minimum inhibitory concentration resultR N Jones, G E Zurenko
Psychological Medicine|July 7, 2000
Dimensions of the Mini-Mental State Examination among community dwelling older adultsR N Jones, J J Gallo
Drugs|March 16, 2000
Oxazolidinones: a reviewD I Diekema, R N Jones
Experimental Dermatology|August 10, 1999
The hydrophobic surface barrier of mammalian hairL N Jones, D E Rivett
Hospital Pharmacy|April 9, 1989
Concurrent review of the duration of antimicrobial prophylaxis in surgeryP D O'Melia, W N Jones
Pageof 367